List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.2.2 Targeted therapies |
Others observations: − Subependymal giant cell astrocytoma |